Cameco Advances Nuclear Partnerships Despite Stock Weakness and Quarterly Disappointment

Cameco declined 37% from its 52-week high despite a U.S.-South Korea framework promising $120 billion in investment for eight Westinghouse reactors in which Cameco holds a 49% stake, plus an exclusive deal to purchase output from a uranium enrichment facility. The stock weakness reflects investor skepticism following a weak second quarter where adjusted earnings of C$0.18 per share missed consensus expectations by more than half, driven by declines in Cameco's Westinghouse earnings. Management indicated that future stock appreciation will require demonstration of actual volume growth and contract wins rather than framework announcements alone.

Cameco's recent quarterly results highlighted a significant earnings miss, with adjusted earnings reaching only C$0.18 per share compared to analyst expectations of C$0.38. The underperformance stemmed primarily from reduced Westinghouse earnings, as the previous year benefited from a Czech contract that did not recur. Despite these headwinds, the company maintained its 2026 production guidance at 19.5 to 21.5 million pounds despite operational challenges including flooding and mine disruptions.

The valuation framework suggests investors are pricing in substantial margin expansion over the next three years. Current operating margins stand at 16.3%, but the model assumes they could nearly double to 30% by 2028, contingent on higher uranium contract prices and increased Westinghouse project activity. This projection relies on uranium prices remaining elevated as existing contracts expire and are renegotiated at higher rates.